- Recommendation ID
- CG173/5
- Question
What is the impact of drug-related adverse effects on health economics and quality of life in neuropathic pain?
- Any explanatory notes
(if applicable) Pharmacological agents for neuropathic pain are associated with various adverse effects. However, there is little evidence about how this affects cost of the quality of life of patients receiving treatment.
Source guidance details
- Comes from guidance
- Neuropathic pain in adults: pharmacological management in non-specialist settings
- Number
- CG173
- Date issued
- November 2013
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 01/09/2020 |